SCHEMBL20880284

SCHEMBL20880284

CC(=O)CNC(=O)C(C(C)C)N(C)C(=O)CCC(C)C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709947 0.81 CA1 (0.35) CA1
SCHEMBL17920111 0.81 CA1 (0.35) CA1
SCHEMBL9915023 0.81 CA1 (0.35) CA1
SCHEMBL16360268 0.74 CA1 (0.38) CA1
SCHEMBL19955121 0.72 KDM4C (0.40) —
SCHEMBL23156984 0.70 CA1 (0.34) CA1
SCHEMBL19751649 0.69 ALDH1A1 (0.47) CA1
SCHEMBL15187247 0.69 MMP9 (0.32) —
SCHEMBL17920016 0.69 MMP9 (0.32) —
SCHEMBL17920012 0.69 MMP9 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3925627-A1 DRUG-CONJUGATES AND USES THEREOF Concortis Biosystems, Corp (US) 2021-12-22 — — EP disclosed
EP-2849790-B1 DRUG-CONJUGATES, CONJUGATION METHODS, AND USES THEREOF CONCORTIS BIOSYSTEMS CORP (US) 2019-04-10 — — EP disclosed
Send feedback